Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Prophylactic transfusion prevents strokes in children with sickle cell anemia who have abnormalities on transcranial Doppler ultrasonographic examination. However, it is not known how long transfusion should be continued in these children. METHODS: We studied children with sickle cell disease who had a high risk of stroke on the basis of a transcranial Doppler screening examination and who had received transfusions for 30 months or longer, during which time the Doppler readings became normal. The children were randomly assigned to continued transfusion or no continued transfusion. Children with severe stenotic lesions on cerebral magnetic resonance angiography were excluded. The composite primary end point was stroke or reversion to a result on Doppler examination indicative of a high risk of stroke. RESULTS: The study was stopped after 79 children of a planned enrollment of 100 underwent randomization. Among the 41 children in the transfusion-halted group, high-risk Doppler results developed in 14 and stroke in 2 others within a mean (+/-SD) of 4.5+/-2.6 months (range, 2.1 to 10.1) of the last transfusion. Neither of these events of the composite end point occurred in the 38 children who continued to receive transfusions. The average of the last two transcranial Doppler results before transfusion was started was the only predictor of the composite end point (P=0.05). CONCLUSIONS: Discontinuation of transfusion for the prevention of stroke in children with sickle cell disease results in a high rate of reversion to abnormal blood-flow velocities on Doppler studies and stroke. (ClinicalTrials.gov number, NCT00006182.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the approximately 22% of children who did not achieve normalization of transcranial Doppler velocity in spite of optimal transfusion in the trial were also protected from stroke (162).”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [162]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Goldstein, L. B., Adams, R., Becker, K., Furberg, C. D., Gorelick, P. B., Hademenos, G., Hill, M., Howard, G., Howard, V. J., Jacobs, B., et al. (2001) · Stroke · doi:10.1161/01.str.32.1.280 · Cited by 905
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Research works printed but not linked: 2
- Ohene-Frempong K, 1998, Blood, 91, 288
- Walters MC, 2000, Blood, 95, 1918
Cited by
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Management of Sickle Cell Disease: Summary of the 2014 Evidence-Based Report by Expert Panel Members
Yawn, B. P., Buchanan, G. R., Afenyi-Annan, A. N., Ballas, S. K., Hassell, K. L., James, A. H., Jordan, L., Lanzkron, S. M., Lottenberg, R., Savage, W. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.10517 · Cited by 1,599
Kato, G. J., Piel, F. B., Reid, C. D., Gaston, M. H., Ohene-Frempong, K., Krishnamurti, L., Smith, W. R., Panepinto, J. A., Weatherall, D. J., Costa, F. F., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.10 · Cited by 1,501
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chan, A. K. C., Goldenberg, N. A., Ichord, R. N., Journeycake, J. M., Nowak-Göttl, U., & Vesely, S. K. (2012) · Chest · doi:10.1378/chest.11-2308 · Cited by 1,491
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Ware, R. E., de Montalembert, M., Tshilolo, L., & Abboud, M. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30193-9 · Cited by 977
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Antithrombotic Therapy in Neonates and Children
Monagle, P., Chalmers, E., Chan, A., deVeber, G., Kirkham, F., Massicotte, P., & Michelson, A. D. (2008) · Chest · doi:10.1378/chest.08-0762 · Cited by 676
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01041-7 · Cited by 515
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Bernaudin, F., Socie, G., Kuentz, M., Chevret, S., Duval, M., Bertrand, Y., Vannier, J.-P., Yakouben, K., Thuret, I., Bordigoni, P., et al. (2007) · Blood · doi:10.1182/blood-2007-03-079665 · Cited by 515
Cruz-Flores, S., Rabinstein, A., Biller, J., Elkind, M. S. V., Griffith, P., Gorelick, P. B., Howard, G., Leira, E. C., Morgenstern, L. B., Ovbiagele, B., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182213e24 · Cited by 507
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
Chou, S. T., Alsawas, M., Fasano, R. M., Field, J. J., Hendrickson, J. E., Howard, J., Kameka, M., Kwiatkowski, J. L., Pirenne, F., Shi, P. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001143 · Cited by 497
DeBaun, M. R., Jordan, L. C., King, A. A., Schatz, J., Vichinsky, E., Fox, C. K., McKinstry, R. C., Telfer, P., Kraut, M. A., Daraz, L., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019001142 · Cited by 434
Transcranial Doppler Ultrasound: Technique and Application
Purkayastha, S., & Sorond, F. (2013) · Seminars in Neurology · doi:10.1055/s-0032-1331812 · Cited by 431
Yazdanbakhsh, K., Ware, R. E., & Noizat-Pirenne, F. (2012) · Blood · doi:10.1182/blood-2011-11-327361 · Cited by 404
Dichgans, M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70028-5 · Cited by 397
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
Ware, R. E., & Helms, R. W. (2012) · Blood · doi:10.1182/blood-2011-11-392340 · Cited by 384
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 360
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Chevret, S., Hau, I., Coïc, L., Leveillé, E., Lemarchand, E., Lesprit, E., et al. (2011) · Blood · doi:10.1182/blood-2010-06-293514 · Cited by 336
Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results
Lee, M. T., Piomelli, S., Granger, S., Miller, S. T., Harkness, S., Brambilla, D. J., Adams, R. J., & for the STOP Study Investigators (2006) · Blood · doi:10.1182/blood-2005-10-009506 · Cited by 319
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70469-0 · Cited by 309
Alexandrov, A. V., Sloan, M. A., Tegeler, C. H., Newell, D. N., Lumsden, A., Garami, Z., Levy, C. R., Wong, L. K. S., Douville, C., Kaps, M., et al. (2012) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2010.00523.x · Cited by 272
Vichinsky, E., Onyekwere, O., Porter, J., Swerdlow, P., Eckman, J., Lane, P., Files, B., Hassell, K., Kelly, P., Wilson, F., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06455.x · Cited by 271
Self-citationKlings, E. S., Machado, R. F., Barst, R. J., Morris, C. R., Mubarak, K. K., Gordeuk, V. R., Kato, G. J., Ataga, K. I., Gibbs, J. S., Castro, O., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201401-0065st · Cited by 263
Central nervous system complications and management in sickle cell disease
DeBaun, M. R., & Kirkham, F. J. (2016) · Blood · doi:10.1182/blood-2015-09-618579 · Cited by 263
Sickle cell disease: a neglected chronic disease of increasing global health importance
Chakravorty, S., & Williams, T. N. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303773 · Cited by 236
Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
Zimmerman, S. A., Schultz, W. H., Burgett, S., Mortier, N. A., & Ware, R. E. (2007) · Blood · doi:10.1182/blood-2006-11-057893 · Cited by 217
Sickle cell disease and stroke
Verduzco, L. A., & Nathan, D. G. (2009) · Blood · doi:10.1182/blood-2009-05-220921 · Cited by 207
Sickle Cell Anemia and Its Phenotypes
Williams, T., & Thein, S. L. (2018) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083117-021320 · Cited by 201
Ballas, S. K., Kesen, M. R., Goldberg, M. F., Lutty, G. A., Dampier, C., Osunkwo, I., Wang, W. C., Hoppe, C., Hagar, W., Darbari, D. S., et al. (2012) · The Scientific World Journal · doi:10.1100/2012/949535 · Cited by 195
Sickle cell disease: when and how to transfuse
Howard, J. (2016) · Hematology · doi:10.1182/asheducation-2016.1.625 · Cited by 195
Chaturvedi, S., & DeBaun, M. R. (2016) · American Journal of Hematology · doi:10.1002/ajh.24235 · Cited by 186
Structure-Function Relations of Human Hemoglobins
Marengo-Rowe, A. J. (2006) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2006.11928171 · Cited by 179
Panepinto, J. A., Walters, M. C., Carreras, J., Marsh, J., Bredeson, C. N., Gale, R. P., Hale, G. A., Horan, J., Hows, J. M., Klein, J. P., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06592.x · Cited by 179
Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 177
Cançado, R. D., & Jesus, J. A. (2007) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842007000300002 · Cited by 172
Advances in transcranial doppler ultrasonography
Tsivgoulis, G., Alexandrov, A. V., & Sloan, M. A. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0008-7 · Cited by 170
Lobitz, S., Telfer, P. T., Cela, E., Allaf, B., Angastiniotis, M., Johansson, C. B., Badens, C., Bento, C., Bouva, M. J., Canatan, D., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15600 · Cited by 166
Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., & Delacourt, C. (2008) · Blood · doi:10.1182/blood-2008-03-143891 · Cited by 162
Understanding Sickle cell disease: Causes, symptoms, and treatment options
Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023) · Medicine · doi:10.1097/md.0000000000035237 · Cited by 161
Recent developments in childhood arterial ischaemic stroke
Amlie‐Lefond, C., Sébire, G., & Fullerton, H. J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70086-3 · Cited by 160
Transfusion therapy for sickle cell disease: a balancing act
Chou, S. T. (2013) · Hematology · doi:10.1182/asheducation-2013.1.439 · Cited by 154
Advances in the Treatment of Sickle Cell Disease
Kapoor, S., Little, J. A., & Pecker, L. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.001 · Cited by 154
Sickle Cell Disease in Sub-Saharan Africa
Williams, T. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.11.005 · Cited by 153
Guidelines on red cell transfusion in sickle cell disease Part II : indications for transfusion
Davis, B. A., Allard, S., Qureshi, A., Porter, J. B., Pancham, S., Win, N., Cho, G., Ryan, K. E., & the British Society for Haematology (2016) · British Journal of Haematology · doi:10.1111/bjh.14383 · Cited by 146
Red cell transfusion and alloimmunization in sickle cell disease
Linder, G., & Chou, S. T. (2021) · Haematologica · doi:10.3324/haematol.2020.270546 · Cited by 145
Tebbi, C. K. (2022) · Hemato · doi:10.3390/hemato3020024 · Cited by 138
Sickle Cell Disease in Childhood
Quinn, C. T. (2013) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2013.09.006 · Cited by 135
Steiner, M. E., Assmann, S. F., Levy, J. H., Marshall, J. C., Pulkrabek, S. M., Sloan, S. R., Triulzi, D. J., & Stowell, C. P. (2010) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2010.05.014 · Cited by 134
A Biophysical Indicator of Vaso-occlusive Risk in Sickle Cell Disease
Wood, D. K., Soriano, A., Mahadevan, L., Higgins, J. M., & Bhatia, S. N. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002738 · Cited by 132
Management of Patients with Sickle Cell Disease Using Transfusion Therapy
Chou, S. T., & Fasano, R. M. (2016) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.01.011 · Cited by 132
McGann, P. T., Hernandez, A. G., & Ware, R. E. (2016) · Blood · doi:10.1182/blood-2016-09-702324 · Cited by 127
Sickle cell disease: Clinical presentation and management of a global health challenge
Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., et al. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.05.004 · Cited by 122
Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
Davis, B. A., Allard, S., Qureshi, A., Porter, J. B., Pancham, S., Win, N., Cho, G., & Ryan, K. E. (2016) · British Journal of Haematology · doi:10.1111/bjh.14346 · Cited by 121
The Pathophysiology of Transfusional Iron Overload
Porter, J. B., & Garbowski, M. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.003 · Cited by 120
Deferasirox: A Review of its Use in the Management of Transfusional Chronic Iron Overload
Yang, L. P. H., Keam, S. J., & Keating, G. M. (2007) · Drugs · doi:10.2165/00003495-200767150-00007 · Cited by 119
The Role of Nutrition in Sickle Cell Disease
Hyacinth, H. I., Gee, B. E., & Hibbert, J. M. (2010) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s5048 · Cited by 119
Transcranial Doppler ultrasonography in neurological surgery and neurocritical care
Bonow, R. H., Young, C. C., Bass, D. I., Moore, A. E., & Levitt, M. R. (2019) · Neurosurgical FOCUS · doi:10.3171/2019.9.focus19611 · Cited by 117
Quality-of-Care Indicators for Children With Sickle Cell Disease
Wang, C.-H. J., Kavanagh, P. L., Little, A. A., Holliman, J. B., & Sprinz, P. G. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1791 · Cited by 115
Pecker, L. H., & Lanzkron, S. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202101190 · Cited by 112
Adams, R. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.11.1567 · Cited by 110
Sporns, P. B., Fullerton, H. J., Lee, S., Kim, H., Lo, W. D., Mackay, M. T., & Wildgruber, M. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00337-x · Cited by 106
Guilliams, K. P., Fields, M. E., Ragan, D. K., Eldeniz, C., Binkley, M. M., Chen, Y., Comiskey, L., Doctor, A., Hulbert, M. L., Shimony, J. S., et al. (2017) · Blood · doi:10.1182/blood-2017-06-789842 · Cited by 106
Adamkiewicz, T. V., Abboud, M. R., Paley, C. S., Olivieri, N. F., Kirby-Allen, M. A., Vichinsky, E. P., Casella, J. F., Alvarez, O. A., Barredo, J. C., Lee, M. T., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203323 · Cited by 105
Epidemiology of Stroke in Sickle Cell Disease
Kirkham, F. J., & Lagunju, I. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184232 · Cited by 104
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010
Miller, S. T., Kim, H., Weiner, D. L., Wager, C. G., Gallagher, D. M., Styles, L. A., Dampier, C., & Roseff, S. D. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03796.x · Cited by 102
Egesa, W. I., Nakalema, G., Waibi, W. M., Turyasiima, M., Amuje, E., Kiconco, G., Odoch, S., Kumbakulu, P. K., Abdirashid, S., & Asiimwe, D. (2022) · International Journal of Pediatrics · doi:10.1155/2022/3885979 · Cited by 101
Bernaudin, F., Verlhac, S., Arnaud, C., Kamdem, A., Hau, I., Leveillé, E., Vasile, M., Kasbi, F., Madhi, F., Fourmaux, C., et al. (2016) · Blood · doi:10.1182/blood-2015-10-675231 · Cited by 101
The excess burden of stroke in hospitalized adults with sickle cell disease
Strouse, J. J., Jordan, L. C., Lanzkron, S., & Casella, J. F. (2009) · American Journal of Hematology · doi:10.1002/ajh.21476 · Cited by 100
Goodnough, L. T., & Panigrahi, A. K. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.09.012 · Cited by 99
Hankinson, T. C., Bohman, L., Heyer, G. L., Licursi, M., Ghatan, S., Feldstein, N. A., & Anderson, R. C. E. (2008) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped/2008/1/3/211 · Cited by 96
Iron Overload in Sickle Cell Disease
Raghupathy, R., Manwani, D. G., & Little, J. A. (2010) · Advances in Hematology · doi:10.1155/2010/272940 · Cited by 95
Neurologic Complications of Sickle Cell Disease
Farooq, S., & Testai, F. D. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0932-0 · Cited by 94
Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia
Fields, M. E., Guilliams, K. P., Ragan, D. K., Binkley, M. M., Mirro, A. E., Fellah, S., Hulbert, M. L., Blinder, M. A., Eldeniz, C., Vo, K. D., et al. (2019) · Blood · doi:10.1182/blood-2018-09-876318 · Cited by 91
Phase1/‐2 study of Pomalidomide in myelofibrosis
Mesa, R. A., Pardanani, A. D., Hussein, K., Wu, W., Schwager, S. M., Litzow, M. R., Hogan, W. J., & Tefferi, A. (2009) · American Journal of Hematology · doi:10.1002/ajh.21598 · Cited by 90
Roseff, S. D. (2009) · Immunohematology · doi:10.21307/immunohematology-2019-234 · Cited by 87
Vichinsky, E. P., Bernaudin, F., Forni, G. L., Gardner, R. V., Hassell, K., Heeney, M. M., Inusa, B. P. D., Kutlar, A., Lane, P. A., Mathias, L., et al. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08720.x · Cited by 85
Challenges in the diagnosis and treatment of pediatric stroke
Jordan, L. C., & Hillis, A. E. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.23 · Cited by 84
The pathophysiology, prevention, and treatment of stroke in sickle cell disease
Wang, W. C. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3280ec5243 · Cited by 84
Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models
Yu, J. M., Heck, S., & Yazdanbakhsh, K. (2007) · American Journal of Hematology · doi:10.1002/ajh.20959 · Cited by 83
Fasano, R. M., & Luban, N. L. C. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.01.006 · Cited by 83
Bernaudin, F., Verlhac, S., de Latour, R. P., Dalle, J., Brousse, V. A. M., Petras, E., Thuret, I., Paillard, C., Neven, B., Galambrun, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20059 · Cited by 81
Transfusional Iron Overload and Iron Chelation Therapy in Thalassemia Major and Sickle Cell Disease
Marsella, M., & Borgna‐Pignatti, C. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2014.04.004 · Cited by 80
Cerebrovascular reserve capacity is impaired in patients with sickle cell disease
Nur, E., Kim, Y.-S., Truijen, J., van Beers, E. J., Davis, S. C. A. T., Brandjes, D. P., Biemond, B. J., & van Lieshout, J. J. (2009) · Blood · doi:10.1182/blood-2009-05-223859 · Cited by 79
Sickle‐cell disease stroke throughout life: A retrospective study in an adult referral center
Guéguen, A., Mahévas, M., Nzouakou, R., Hosseini, H., Habibi, A., Bachir, D., Brugière, P., Lionnet, F., Ribeil, J., Godeau, B., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23625 · Cited by 79
Abboud, M. R., Yim, E., Musallam, K. M., Adams, R. J., & for the STOP II Study Investigators (2011) · Blood · doi:10.1182/blood-2010-12-326298 · Cited by 78
Transcranial D oppler ultrasound in neurovascular diseases: diagnostic and therapeutic aspects
Topçuoğlu, M. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07942.x · Cited by 78
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease
Wang, W. C., & Dwan, K. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003146.pub2 · Cited by 78
Sickle Cell Disease and Stroke
Hirtz, D., & Kirkham, F. J. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.02.018 · Cited by 76
Drašar, E., Igbineweka, N. E., Vasavda, N., Free, M., Awogbade, M., Allman, M., Mijović, A., & Thein, S. L. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08451.x · Cited by 75
Stroke in patients with sickle cell disease
Webb, J. L., & Kwiatkowski, J. L. (2013) · Expert Review of Hematology · doi:10.1586/ehm.13.25 · Cited by 74
Weight Status of Children With Sickle Cell Disease
Chawla, A., Sprinz, P. G., Welch, J. J. G., Heeney, M. M., Usmani, N., Pashankar, F., & Kavanagh, P. L. (2013) · PEDIATRICS · doi:10.1542/peds.2012-2225 · Cited by 73
Cerebrovascular disease and stroke
Pappachan, J., & Kirkham, F. J. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2008.142836 · Cited by 73
Thalassemia intermedia today: should patients regularly receive transfusions?
Aessopos, A., Kati, M., & Meletis, J. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01192.x · Cited by 72
Prabhakar, H., Haywood, C., & Molokie, R. E. (2010) · American Journal of Hematology · doi:10.1002/ajh.21676 · Cited by 71
Clinical management of adult sickle-cell disease
Bartolucci, P., & Galactéros, F. (2012) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328351c35f · Cited by 69
Treatment Options for Sickle Cell Disease
Meier, E. R. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.01.005 · Cited by 68
Metadata
- Authors
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Affiliations
- Augusta University (US)
- Corresponding author
- The Optimizing Primary Stroke Prevention in Sickle Cell Anemia (STOP 2) Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-12-29
- Volume
- 353
- Issue
- 26
- Pages
- 2769-2778
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1498156640
- Cited by
- 635
- References
- 27
- Citations by year
- 2026: 23 · 2025: 12 · 2024: 31 · 2023: 22 · 2022: 29 · 2021: 27 · 2020: 34 · 2019: 25 · 2018: 35 · 2017: 37 · 2016: 43 · 2015: 25 · 2014: 32 · 2013: 32 · 2012: 45
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (U01HL052193, U01HL052016)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, stroke prevention, prophylactic transfusion, transcranial Doppler screening, cerebral blood flow velocity, children
- MeSH terms
- Adolescent, Adult, Anemia, Sickle Cell, Blood Flow Velocity, Blood Transfusion, Brain, Child, Female, Humans, Magnetic Resonance Imaging, Male, Risk, Chelation Therapy, Ultrasonography, Doppler, Transcranial, Stroke, Middle Cerebral Artery, Withholding Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.